Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Carrick

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Journal of the American Heart Association|February 25, 2016
Temporal Evolution of Myocardial Hemorrhage and Edema in Patients After Acute ST-Segment Elevation Myocardial Infarction: Pathophysiological Insights and Clinical ImplicationsDavid Carrick, Caroline Haig, Nadeem Ahmed, et al.
JACC. Cardiovascular Imaging|June 22, 2015
Pathophysiology of LV Remodeling in Survivors of STEMI: Inflammation, Remote Myocardium, and PrognosisDavid Carrick, Caroline Haig, Sam Rauhalammi, et al.
JCI Insight|October 5, 2016
Microvascular resistance of the culprit coronary artery in acute ST-elevation myocardial infarctionDavid Carrick, Caroline Haig, Jaclyn Carberry, et al.
JACC. Cardiovascular Imaging|March 11, 2022
A Noncontrast CMR Risk Score for Long-Term Risk Stratification in Reperfused ST-Segment Elevation Myocardial InfarctionHeerajnarain Bulluck, Jaclyn Carberry, David Carrick, et al.
NEJM Evidence|February 6, 2024
Dapagliflozin in Myocardial Infarction without Diabetes or Heart FailureStefan James, David Erlinge, Robert F Storey, et al.
Journal of the American College of Cardiology|March 4, 2014
A randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI)David Carrick, Keith G Oldroyd, Margaret McEntegart, et al.
Heart (British Cardiac Society)|November 27, 2024
Coronary microvascular function and atherosclerotic plaque burden in ischaemia and no obstructive coronary arteries: a secondary analysis of the CorMicA trialDaniel T Y Ang, Jaclyn Carberry, Thomas J Ford, et al.
Hypertension (Dallas, Tex. : 1979)|July 18, 2018
Hypertension, Microvascular Pathology, and Prognosis After an Acute Myocardial InfarctionDavid Carrick, Caroline Haig, Annette M Maznyczka, et al.
JACC. Cardiovascular Interventions|October 11, 2023
The Index of Microcirculatory Resistance After Primary PCI: A Pooled Analysis of Individual Patient DataMohamed El Farissi, Frederik M Zimmermann, Giovanni Luigi De Maria, et al.
JACC. Cardiovascular Imaging|July 23, 2018
Current Smoking and Prognosis After Acute ST-Segment Elevation Myocardial Infarction: New Pathophysiological InsightsCaroline Haig, David Carrick, Jaclyn Carberry, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Journal of the American Heart Association|February 25, 2016
Temporal Evolution of Myocardial Hemorrhage and Edema in Patients After Acute ST-Segment Elevation Myocardial Infarction: Pathophysiological Insights and Clinical ImplicationsDavid Carrick, Caroline Haig, Nadeem Ahmed, et al.
JACC. Cardiovascular Imaging|June 22, 2015
Pathophysiology of LV Remodeling in Survivors of STEMI: Inflammation, Remote Myocardium, and PrognosisDavid Carrick, Caroline Haig, Sam Rauhalammi, et al.
JCI Insight|October 5, 2016
Microvascular resistance of the culprit coronary artery in acute ST-elevation myocardial infarctionDavid Carrick, Caroline Haig, Jaclyn Carberry, et al.
JACC. Cardiovascular Imaging|March 11, 2022
A Noncontrast CMR Risk Score for Long-Term Risk Stratification in Reperfused ST-Segment Elevation Myocardial InfarctionHeerajnarain Bulluck, Jaclyn Carberry, David Carrick, et al.
NEJM Evidence|February 6, 2024
Dapagliflozin in Myocardial Infarction without Diabetes or Heart FailureStefan James, David Erlinge, Robert F Storey, et al.
Journal of the American College of Cardiology|March 4, 2014
A randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI)David Carrick, Keith G Oldroyd, Margaret McEntegart, et al.
Heart (British Cardiac Society)|November 27, 2024
Coronary microvascular function and atherosclerotic plaque burden in ischaemia and no obstructive coronary arteries: a secondary analysis of the CorMicA trialDaniel T Y Ang, Jaclyn Carberry, Thomas J Ford, et al.
Hypertension (Dallas, Tex. : 1979)|July 18, 2018
Hypertension, Microvascular Pathology, and Prognosis After an Acute Myocardial InfarctionDavid Carrick, Caroline Haig, Annette M Maznyczka, et al.
JACC. Cardiovascular Interventions|October 11, 2023
The Index of Microcirculatory Resistance After Primary PCI: A Pooled Analysis of Individual Patient DataMohamed El Farissi, Frederik M Zimmermann, Giovanni Luigi De Maria, et al.
JACC. Cardiovascular Imaging|July 23, 2018
Current Smoking and Prognosis After Acute ST-Segment Elevation Myocardial Infarction: New Pathophysiological InsightsCaroline Haig, David Carrick, Jaclyn Carberry, et al.
Pageof 8